ABVC BioPharma, Inc. (ABVC) Net margin 2018–2025
ABVC BioPharma, Inc. (ABVC) net profit margin by fiscal year — reported net income divided by reported revenue.
-2671.8%FY2025 · since FY2018: -87184.2% → -2671.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -2671.8% | -1709.7 pp |
| FY2024 | -962.1% | +4147.1 pp |
| FY2023 | -5109.3% | -3415.8 pp |
| FY2022 | -1693.5% | +1915.0 pp |
| FY2021 | -3608.5% | -1415.4 pp |
| FY2020 | -2193.1% | -1632.6 pp |
| FY2019 | -560.5% | +86623.6 pp |
| FY2018 | -87184.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ABVC financial trends
ABVC RevenueABVC Net incomeABVC Gross profitABVC Gross marginABVC Operating incomeABVC Operating marginABVC Operating cash flowABVC Free cash flowABVC Capital expendituresABVC Return on equityABVC Stock buybacksABVC Dividends paidABVC Total assetsABVC Total liabilitiesABVC Shareholders’ equityABVC overview →